Factorial Partners’s Pfizer PFE Stock Holding History

Factorial Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-43,200	Closed	-$1.43M	–	87
2023 Q3	$1.43M	Sell	43,200 -11,000	-20%	-$389K	1.05%	40
2023 Q2	$1.99M	Sell	54,200 -14,000	-21%	-$545K	1.37%	25
2023 Q1	$2.78M	Buy	68,200 +2,000	+3%	+$86.4K	2.1%	15
2022 Q4	$3.39M	Buy	66,200 +600	+0.9%	+$28.8K	2.6%	10
2022 Q3	$2.87M	Sell	65,600 -3,100	-5%	-$151K	2.49%	11
2022 Q2	$3.6M	Sell	68,700 -5,500	-7%	-$280K	2.93%	5
2022 Q1	$3.84M	Buy	74,200 +58,800	+382%	+$3.05M	2.64%	7
2021 Q4	$909K	Buy	+15,400	New	+$763K	0.6%	61

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Factorial Partners's PFE Position: Q4 2023 in Review

Factorial Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 43,200 shares — an estimated $1.43M sold.

Factorial Partners first reported a position in PFE in Q4 2021 and held it in 8 quarters. The position peaked at $3.84M in Q1 2022. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Factorial Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Factorial Partners sold 43,200 Pfizer shares in Q4 2023, an estimated $1.43M.
Factorial Partners first reported a position in Pfizer in Q4 2021 and held it in 8 quarters.
Factorial Partners's Pfizer position peaked at $3.84M in Q1 2022.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Factorial Partners's 13F filing for Q4 2023, filed 13 Feb 2024.